Precision Medicine

Optimising Prescribing in Type 2 Diabetes: Updating a Five-Drug Class Treatment Selection Model to Include NewerGLP-1 Receptor Agonists

by Prateek Chopra | June 29, 2026 | Diabetes Conferences | ADA 2026 Precision Medicine in T2D Methods Study Population Model Performance Key Findings Clinical Implications The updated five-drug class prediction model accurately predicts HbA1c responses to both oral and subcutaneous semaglutide. Successful external validation supports its use as a precision medicine tool for individualized treatment selection in type 2 […]

Optimising Prescribing in Type 2 Diabetes: Updating a Five-Drug Class Treatment Selection Model to Include NewerGLP-1 Receptor Agonists Read Post »

Leave a Comment / Diabetes Conferences / / / , , , , ,

Insulin Resistance: A Cause or Consequence of Metabolic Dysfunction? A Genetic Perspective with Evidence for the Existence of Both

by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Research Objective: Sources of Evidence: Evidence for Primary Insulin Resistance: Evidence for Secondary Insulin Resistance: Insights from Polygenic Analyses: Implications for Diabetes Risk Stratification: Human genetic evidence indicates that insulin resistance arises through multiple biological pathways rather than a

Insulin Resistance: A Cause or Consequence of Metabolic Dysfunction? A Genetic Perspective with Evidence for the Existence of Both Read Post »

Leave a Comment / Diabetes Conferences / / / , , , ,
Scroll to Top